Physician profile

Cynthia Anna Schandl

Clinical Pathology/Laboratory Medicine · Charleston, SC

NPI 1770507691

$92,627.25

in general payments reported to CMS, 2019-2025

4 companies · $4,692 in 2025

The $4,692 reported for 2025 was more than what 82% of Clinical Pathology/Laboratory Medicine providers received nationally (typical 2025 total: $114).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$47,562.50
Travel and Lodging$15,265.66
Food and Beverage$1,076.33

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Lilly USA, LLC $92,490.47 2021-2025
Hologic Sales and Service, LLC $88.74 2022
Oxford Gene Technology INC $28.91 2025
Gen-Probe, INC. $19.13 2022

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Cynthia Anna Schandl

$92,627.25

in general payments reported 2019-2025

Years
2021-2025
Top company
Lilly USA, LLC
Context
The $4,692 reported for 2025 was more than what 82% of Clinical Pathology/Laboratory Medicine providers received nationally (typical 2025 total: $114).

https://glasscript.com/doctor/641590/cynthia-anna-schandl

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.